The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population.
about
Evaluation and management of overactive bladder: strategies for optimizing careEffects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic reviewAnalysis of the prevalence and associated factors of overactive bladder in adult Korean men.Toileting behaviors and overactive bladder in patients with type 2 diabetes: a cross-sectional study in China.Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies.The Problem of Polypharmacy in Female Patients with Overactive Bladders - Cross-Sectional Study in a Specialist Outpatient Department.Fesoterodine in randomised clinical trials: an updated systematic clinical review of efficacy and safety.Management of OAB in those over age 65.Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management.Does the diagnosis of detrusor overactivity affect the long-term prognosis of patients treated with a retropubic midurethral sling?Analysis of the prevalence of and factors associated with overactive bladder in adult Korean women.Correlation of pelvic organ prolapse staging with lower urinary tract symptoms, sexual dysfunction, and quality of life.Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines?OAB score: a clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study.Assessment, diagnosis and treatment of urinary incontinence in women.Comorbidities associated with bladder dysfunction.Lower urinary tract symptoms in female patients with pelvic organ prolapse: efficacy of pelvic floor reconstruction.Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?Does concomitant anterior/apical repair during midurethral sling improve the overactive bladder component of mixed incontinence?Risk factors and factors affecting the severity of overactive bladder symptoms in Korean women who use public health centers.
P2860
Q26739217-E45E8289-DE30-4AAC-B571-AE1B545F63F7Q28273396-2B56EB59-4F12-4B18-9F79-E9E05DB0685BQ33563105-B8CEA9A7-4280-45D6-AD9B-C8548C3757A9Q33796087-2FF136A1-D4D0-43EE-9DC6-FB94B1493DB5Q35510256-D026EFBD-D115-499B-9DF1-EC1F5B232394Q37540338-F4B98C46-72DA-491C-99B6-7AE4A0E27C1CQ37992884-94247E33-623A-46FA-972E-61F3F2653D77Q38127155-36476FDB-642A-4122-B3C3-1B417E26AE1EQ39385514-D1B05B34-6255-486D-9A40-696ED1D90B06Q39692185-A45054F5-6E56-4754-ADE9-713408975795Q42366273-9303870E-81A3-4FF2-99BF-77248D3638B7Q44557480-DD118383-7B23-4404-9792-0FED58F0541EQ47117943-B0E4ED92-78D2-4C8A-91B7-FD230D0B09B2Q47568495-9391094C-3189-47E3-97AE-CB3B0E90D4F7Q47814188-6BA3A48E-9B2D-4027-91B8-380B748ED532Q50728227-0A9ABC93-E232-4F60-A861-8F773618FA71Q51194782-AB4CA7BF-8BDF-4950-A79A-6F7DD57FF43BQ51269674-AE9FEF81-E79F-4BAE-A65A-9F4C7D85A8C0Q53556057-01C5A396-9B4D-4EC7-949D-F6F8A65E859CQ55302905-60073CB8-FFE3-4131-84AA-AF94B8F46641
P2860
The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The prevalence and risk factor ...... n a general female population.
@ast
The prevalence and risk factor ...... n a general female population.
@en
The prevalence and risk factor ...... n a general female population.
@nl
type
label
The prevalence and risk factor ...... n a general female population.
@ast
The prevalence and risk factor ...... n a general female population.
@en
The prevalence and risk factor ...... n a general female population.
@nl
prefLabel
The prevalence and risk factor ...... n a general female population.
@ast
The prevalence and risk factor ...... n a general female population.
@en
The prevalence and risk factor ...... n a general female population.
@nl
P2093
P2860
P1476
The prevalence and risk factor ...... n a general female population.
@en
P2093
Curt W Burger
Marijke C P Slieker-ten Hove
Mark E Vierhout
Tiny A de Boer
P2860
P2888
P304
P356
10.1007/S00192-010-1323-X
P577
2010-11-23T00:00:00Z
P5875
P6179
1041883592